Ariose Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-37,900	Closed	-$2.38M	–	7
2022 Q1	$2.38M	Hold	37,900	–	–	9.3%	5
2021 Q4	$2.87M	Buy	+37,900	New	+$2.87M	6.78%	7